Table 2.
Clinically relevant | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Not clinically significant | Subthreshold | Moderate | Severe | Total | ||||||||||||||||
M | W | T | M/W | M | W | T | M/W | M | W | T | M/W | M | W | T | M/W | M | W | T | M/W | |
N | 17 | 39 | 56 | 41 | 105 | 146 | 29 | 81 | 110 | 10 | 30 | 40 | 97 | 255 | 352 | |||||
Distribution (%) | 4.8 | 11.1 | 15.9 | 1:2.3 | 11.6 | 29.8 | 41.5 | 1:2.6 | 8.2 | 23 | 31.2 | 1:2.8 | 2.8 | 8.6 | 11.4 | 1:3 | 27.5 | 72.5 | 100 | 1:2.6 |
Proportion (%) within gender | 17.5 | 15.3 | 1.1:1 | 42.2 | 41.2 | 1:1 | 29.9 | 31.8 | 1:1.1 | 10.3 | 11.8 | 1:1.2 | ||||||||
Prevalence (%) (952 pts) | 1.8 | 4.1 | 5.9 | 1:2.8 | 4.3 | 11.0 | 15.3 | 1:2.6 | 3.0 | 8.5 | 11.5 | 1:2.8 | 1.1 | 3.2 | 4.3 | 1:2.9 | 10.2 | 26.8 | 37 | 1:2.6 |
Prevalence (%) within gender (290 M, 662 W) | 5.9 | 5.9 | 1:1 | 14.1 | 15.9 | 1:1.1 | 10 | 12.2 | 1:1.2 | 3.5 | 4.5 | 1:1.3 |
M/W, ratio men to women; pts, patients.